Training Program In The Neurobiology Of Cognition And Cognitive Disorders
认知和认知障碍神经生物学培训计划
基本信息
- 批准号:9104203
- 负责人:
- 金额:$ 23.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This is a competitive renewal application for the Training Program in Neurobiology of Cognition and Cognitive Disorders at the University of Alabama at Birmingham (C&CD Program). Since the C&CD Program was implemented in 2007 under the leadership of Dr. David Sweatt, UAB has made an impressive investment in neuroscience with the areas of cognition and cognitive disorders now being identified as a focal point for strategic development across the entire institution. The C&CD Program is housed in the Department of Neurobiology, and includes 47 faculty from 11 basic science and clinical departments in the School of Medicine (SoM), School of Optometry, and College of Arts and Sciences. The goal of the C&CD Program is to develop the next generation of leaders and scholars in neuroscience research who: have a foundation in molecular, cellular, and cognitive neuroscience theories and research findings; value the importance of using findings from basic science to understanding the basis of cognitive disorders; are prepared to use innovative research approaches to understand cognition and brain-behavior relationships; and will be able to translate this knowledge to treatments and cures of cognitive disorders in the future. The success of the C&CD Program in its first funding period is evidenced by its robust participation (35 total students-18 trainees funded), graduation of a talented cadre of doctoral students (ten total graduates-six funded), with an average of more than four publications each, and all transitioning to competitive postdoctoral positions or completing clinical training. This renewal builds on the successful components of the Program Plan by providing: (1) A curriculum with courses in cellular, molecular, cognitive and translational neuroscience; (2) Clinical shadowing in the "Clinical Evaluation of Cognitive Disorders" course; (3) An outstanding seminar series; (4) Dissertation research with both a basic science and clinical mentor, using experimental approaches that address questions with direct relevance to cognition and cognitive disorders; and (5) Opportunities to hone presentation skills at retreats and national meetings, and instruction in ethical conduct of research, and career development. The specific "value added" components of the C&CD Program include the special clinical/translational training experience in patient-oriented research, interactions with both basic science and clinician scientist mentors,
and distinct extracurricular activities. As the UAB SoM Strategic Plan highlighted cognition and cognitive diseases as an area for major investment with 15 new faculty and $20 million over the next five years, the future of the C&CD Program is secure and it will benefit substantially from this investment with the addition of dynamic new faculty mentors and research facilities.
描述(由申请人提供):这是阿拉巴马大学伯明翰大学(C&CD计划)的认知和认知障碍神经生物学培训计划的竞争更新申请。由于C&D计划于2007年在David Sweatt博士的领导下实施,因此UAB对神经科学进行了令人印象深刻的投资,而这些认知和认知障碍领域现在被确定为整个机构战略发展的焦点。 C&C CD计划位于神经生物学系,包括来自医学院(SOM),验光学院和艺术与科学学院的11个基础科学和临床系的47位教职员工。 C&D计划的目的是发展神经科学研究的下一代领导者和学者,他们:在分子,细胞和认知神经科学理论和研究结果方面拥有基础;重视使用基础科学发现的重要性来理解认知障碍的基础;准备使用创新的研究方法来了解认知和脑行为关系;并将能够将这些知识转化为未来认知障碍的治疗方法。 C&D计划在其第一个资金期间的成功得到了强大的参与(总计35名学生资助的学生),才华横溢的博士生干部的毕业(十个总毕业生六名资助),每个人平均每个出版物平均有四个以上的出版物,所有这些出版物都过渡到有竞争性的上一职或完成临床培训。这种更新是基于程序计划的成功组成部分的基础:(1)课程,其中包括细胞,分子,认知和转化神经科学的课程; (2)“认知障碍临床评估”课程中的临床阴影; (3)出色的研讨会系列; (4)使用基础科学和临床导师的论文研究,使用实验方法解决与认知和认知障碍直接相关的问题; (5)有机会在务虚会和国家会议上磨练陈述技巧,以及有关研究的道德行为和职业发展的指导。 C&D计划的具体“增值”组成部分包括针对患者研究的特殊临床/转化培训经验,与基础科学和临床医生的辅导员的互动,
和独特的课外活动。随着UAB SOM战略计划强调认知和认知疾病是主要投资的领域,在未来五年内,C&D计划的未来是安全的,并且将在这项投资中得到确保,并增加了动态的新教师的导师和研究设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John J. Hablitz其他文献
A technique for recording the electroretinogram (ERG) from chronically implanted electrodes in animals
- DOI:
10.1016/0042-6989(74)90219-3 - 发表时间:
1974-11-01 - 期刊:
- 影响因子:
- 作者:
Robert P. Borda;John J. Hablitz - 通讯作者:
John J. Hablitz
Electroencephalographic changes induced by cerebellar stimulation in freely moving primates
- DOI:
10.1016/0006-8993(74)90750-1 - 发表时间:
1974-07-26 - 期刊:
- 影响因子:
- 作者:
John J. Hablitz;Joseph W. McSherry;Peter Kellaway - 通讯作者:
Peter Kellaway
John J. Hablitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John J. Hablitz', 18)}}的其他基金
Acquired HCN Channelopathies in Cortical Dysplasia
皮质发育不良中获得性 HCN 通道病
- 批准号:
9091651 - 财政年份:2014
- 资助金额:
$ 23.23万 - 项目类别:
Acquired HCN Channelopathies in Cortical Dysplasia
皮质发育不良中获得性 HCN 通道病
- 批准号:
8808163 - 财政年份:2014
- 资助金额:
$ 23.23万 - 项目类别:
Presynaptic NMDA receptors and GABA release in cortical dysplasia
皮质发育不良中突触前 NMDA 受体和 GABA 释放
- 批准号:
7516663 - 财政年份:2008
- 资助金额:
$ 23.23万 - 项目类别:
Training Program in the Neurobiology of Cognition and Cognitive Disorders
认知和认知障碍神经生物学培训计划
- 批准号:
10425394 - 财政年份:2008
- 资助金额:
$ 23.23万 - 项目类别:
Training Program in the Neurobiology of Cognition and Cognitive Disorders
认知和认知障碍神经生物学培训计划
- 批准号:
10197225 - 财政年份:2008
- 资助金额:
$ 23.23万 - 项目类别:
Training Program In The Neurobiology Of Cognition And Cognitive Disorders
认知和认知障碍神经生物学培训计划
- 批准号:
9302835 - 财政年份:2008
- 资助金额:
$ 23.23万 - 项目类别:
相似国自然基金
星形胶质细胞糖代谢重编程介导Lactoferrin基因缺失引发的早期生长迟缓和认知障碍
- 批准号:32371037
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
数字疗法在轻度认知障碍患者居家康复中的应用与评价
- 批准号:82360673
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
电针治疗卒中后认知障碍新机制:下调HK2介导的海马Warburg效应调控小胶质细胞极化缓解神经炎症
- 批准号:82305403
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于LTP样可塑性的TMS对轻度认知障碍精准评定与干预的机制研究
- 批准号:82372582
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于“额叶保持,颞叶损伤”假说的成功认知老化与轻度认知障碍脑功能影像机制研究
- 批准号:32300924
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Illumination of TAAR2 Location, Function and Regulators
TAAR2 位置、功能和调节器的阐明
- 批准号:
10666759 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别:
The role of loneliness in cognitive decline and risk for dementia
孤独在认知能力下降和痴呆风险中的作用
- 批准号:
10646826 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别:
2023 Catecholamines Gordon Research Conference and Gordon Research Seminar
2023年儿茶酚胺戈登研究会议暨戈登研究研讨会
- 批准号:
10753909 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别:
Cognitive and brain imaging correlates of apathy- components in asymptomatic middle aged individuals at high ADRD- risk
认知和脑成像与 ADRD 高风险无症状中年个体的冷漠成分相关
- 批准号:
10875019 - 财政年份:2023
- 资助金额:
$ 23.23万 - 项目类别: